Janssen Pharmaceuticals recalls

Janssen Pharmaceuticals has 4 recalls on record with the FDA and USDA, the earliest in 2014 and the latest reported on 14 Nov 2018. The most frequent reason is sterility.

Total recalls4since 2014

Last 12 months0reported

Class I00% of total

Ongoing0latest 14 Nov 2018

Recalls per month, last 24 months

click a bar for that month

0Nov '24 0 0 0Feb 0 0 0May 0 0 0Aug 0 0 0Nov 0 0 0Feb 0 0 0May 0 0 0Aug 0 0

Severity split

Class I 0 0%Class II 4 100%Class III 0 0%

Why janssen pharmaceuticals is recalled

Product types

Hormones & Birth Control375%

By year

2018250%
2015125%
2014125%

All janssen pharmaceuticals recalls, newest first

4 total

Reported	Class	Recall	Company	Reason	Where
14 Nov 2018Drug	CLASS II	Ortho-Novum 7/7/7 (norethindrone/ethinyl/estradiol) Tablets recalled	Janssen Pharmaceuticals	Packaging Defects	Nationwide
14 Nov 2018Drug	CLASS II	Ortho-Novum 1/35 (norethindrone/ethinyl estradiol) Tablets recalled	Janssen Pharmaceuticals	Other	Nationwide
20 May 2015Drug	CLASS II	Ortho-Cept (0.15 mg desogestrel recalled by Janssen Pharmaceuticals	Janssen Pharmaceuticals	Potency & Assay	Nationwide
13 Aug 2014Drug	CLASS II	Risperdal Consta (risperiDONE), 25 mg Dose Pack recalledRisperdal Consta	Janssen Pharmaceuticals	Sterility	Nationwide

About this list

Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.